Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New antipsychotic agents from Janssen

Oct. 4, 1996

5-HT2B/2C antagonists disclosed by SKB

Oct. 4, 1996

Novel benzodiazepine derivatives from Roche

Oct. 4, 1996

Merck & Co. reports 5-HT1Dalpha receptor agonists

Oct. 4, 1996

Janssen describes vasoconstrictors for migraine Rx

Oct. 4, 1996

Potential of cannabinoid derivative in pain and inflammation

Oct. 4, 1996

Tachykinin antagonists disclosed by Sanofi

Oct. 4, 1996

Glaxo Wellcome prepares a novel class of glycine-site NMDA receptor antagonists

Sep. 27, 1996

Yamanouchi describes AMPA antagonists for stroke

Sep. 27, 1996

Sagami prepares NGF production-enhancing compounds

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...